These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7295036)

  • 1. Manifestation of carcinogenesis as a stochastic process on the basis of an altered mitochondrial genome.
    Neubert D; Hopfenmüller W; Fuchs G
    Arch Toxicol; 1981 Sep; 48(2-3):89-125. PubMed ID: 7295036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell proliferation not associated with carcinogenesis in rodents and humans.
    Ward JM; Uno H; Kurata Y; Weghorst CM; Jang JJ
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):125-35. PubMed ID: 8013399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aneuploidy, the somatic mutation that makes cancer a species of its own.
    Duesberg P; Rasnick D
    Cell Motil Cytoskeleton; 2000 Oct; 47(2):81-107. PubMed ID: 11013390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation and carcinogenesis models: general principles with illustrations from the rodent liver system.
    Moolgavkar SH
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):91-4. PubMed ID: 8013431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline passage of mitochondria: quantitative considerations and possible embryological sequelae.
    Jansen RP
    Hum Reprod; 2000 Jul; 15 Suppl 2():112-28. PubMed ID: 11041519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication.
    Yamasaki H
    Toxicol Lett; 1995 May; 77(1-3):55-61. PubMed ID: 7618169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenesis: basic principles.
    Couch DB
    Drug Chem Toxicol; 1996 Aug; 19(3):133-48. PubMed ID: 8933020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aneuploidy precedes and segregates with chemical carcinogenesis.
    Duesberg P; Li R; Rasnick D; Rausch C; Willer A; Kraemer A; Yerganian G; Hehlmann R
    Cancer Genet Cytogenet; 2000 Jun; 119(2):83-93. PubMed ID: 10867141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-hit kinetics of tumor formation, with special reference to experimental liver and human lung carcinogenesis and some gneral conclusions.
    Emmelot P; Scherer E
    Cancer Res; 1977 Jun; 37(6):1702-8. PubMed ID: 870184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the mitochondrial-DNA mutation hypothesis of cell aging.
    Miquel J
    Mutat Res; 1992 Sep; 275(3-6):209-16. PubMed ID: 1383762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria, cell surface, and carcinogenesis.
    Wilkie D; Evans IH; Egilsson V; Diala ES; Collier D
    Int Rev Cytol Suppl; 1983; 15():157-89. PubMed ID: 6343282
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinogenesis: a late effect of irreversible toxic damage during development.
    Rice JM
    Environ Health Perspect; 1976 Dec; 18():133-9. PubMed ID: 1030391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcinogenesis: from epidemiology to molecular biology].
    Tubiana M
    Bull Acad Natl Med; 1998; 182(1):19-29; discussion 29-31. PubMed ID: 9622929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.